Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (251-260 of 427) with videos related to

Pageof 43
Sort By:
BMC Medicine|February 21, 2025
Normal-weight central obesity and cardiometabolic disorders among Aboriginal and Torres Strait Islander AustraliansKedir Y Ahmed, Utpal K Mondal, M Mamun Huda, et al.
Radiology|March 1, 2022
CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic OutcomesRocio Perez-Johnston, Jose A Araujo-Filho, James G Connolly, et al.
Ebiomedicine|October 11, 2020
MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancerAlmir G V Bitencourt, Peter Gibbs, Carolina Rossi Saccarelli, et al.
JNCI Cancer Spectrum|March 1, 2023
Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetesSuzanne G Orchard, Jessica E Lockery, Jonathan C Broder, et al.
International Journal of Cancer|August 14, 2015
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteriaNatalie Turner, Hui-Li Wong, Arnoud Templeton, et al.
Oncoimmunology|September 14, 2016
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancerRosemary Millen, Jordane Malaterre, Ryan S Cross, et al.
BJUI Compass|September 17, 2025
Perioperative chemotherapy use and related outcomes in muscle-invasive bladder cancer in AustraliaAlison Hiong, James Lynam, Andrew Weickhardt, et al.
Expert Review of Anticancer Therapy|March 25, 2016
Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015Timothy J Price, Subotheni Thavaneswaran, Matthew Burge, et al.
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysisGrace Chazan, Angelyn Anton, Shirley Wong, et al.
International Journal of Cancer|March 17, 2021
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease settingLouise Kostos, Wei Hong, Belinda Lee, et al.
Pageof 43

Showing results (251-260 of 427) with videos related to

Sort By:
Pageof 43
BMC Medicine|February 21, 2025
Normal-weight central obesity and cardiometabolic disorders among Aboriginal and Torres Strait Islander AustraliansKedir Y Ahmed, Utpal K Mondal, M Mamun Huda, et al.
Radiology|March 1, 2022
CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic OutcomesRocio Perez-Johnston, Jose A Araujo-Filho, James G Connolly, et al.
Ebiomedicine|October 11, 2020
MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancerAlmir G V Bitencourt, Peter Gibbs, Carolina Rossi Saccarelli, et al.
JNCI Cancer Spectrum|March 1, 2023
Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetesSuzanne G Orchard, Jessica E Lockery, Jonathan C Broder, et al.
International Journal of Cancer|August 14, 2015
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteriaNatalie Turner, Hui-Li Wong, Arnoud Templeton, et al.
Oncoimmunology|September 14, 2016
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancerRosemary Millen, Jordane Malaterre, Ryan S Cross, et al.
BJUI Compass|September 17, 2025
Perioperative chemotherapy use and related outcomes in muscle-invasive bladder cancer in AustraliaAlison Hiong, James Lynam, Andrew Weickhardt, et al.
Expert Review of Anticancer Therapy|March 25, 2016
Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015Timothy J Price, Subotheni Thavaneswaran, Matthew Burge, et al.
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysisGrace Chazan, Angelyn Anton, Shirley Wong, et al.
International Journal of Cancer|March 17, 2021
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease settingLouise Kostos, Wei Hong, Belinda Lee, et al.
Pageof 43